Upperton offers analytical services designed to support the development, monitoring, and quality control testing of pharmaceutical products. Our analytical team focus on understanding the physico-chemical properties of active pharmaceutical ingredients (APIs), as well as identifying potential stability challenges and excipient incompatibilities that may arise during product development.

Upperton uses a variety of techniques, including Differential Scanning Calorimetry, X-ray Powder Diffraction, Thermal Gravimetric Analysis, microscopy, and Fourier-transform Infrared Spectroscopy, to gain insights into the behaviour of APIs. This forms the basis for supporting FIH studies and product development.

In terms of stability testing, Upperton integrates ASAPprime® into its development programs. This accelerated stability testing provides early indications of potential stability issues, allowing for faster decision-making to save time and resources.

By employing a wide range of techniques and offering comprehensive analytical support, Upperton helps clients mitigate risks, improve product performance, and ensure quality throughout the drug development cycle.